Anthelmintic Studies on Pyrvinium Pamoate (Povan) and Other Drugs in Rodents, Dogs, and Monkeys

Paul E. Thompson Research Division, Parke, Davis & Company, Ann Arbor, Michigan

Search for other papers by Paul E. Thompson in
Current site
Google Scholar
PubMed
Close
,
David E. Worley Research Division, Parke, Davis & Company, Ann Arbor, Michigan

Search for other papers by David E. Worley in
Current site
Google Scholar
PubMed
Close
, and
Jack E. Meisenhelder Research Division, Parke, Davis & Company, Ann Arbor, Michigan

Search for other papers by Jack E. Meisenhelder in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

Pyrvinium pamoate (Povan®) removed Syphacia obvelata and Aspiculuris tetraptera from mice when given either in the diet or as a single oral dose. S. muris in rats also was readily susceptible to pyrvinium pamoate but Nematospiroides dubius and Hymenolepis nana in mice were not. Multiple oral doses efficiently removed ascarids and hookworms in dogs but failed to remove whipworms.

The relationship of these effects to those of pyrvinium chloride is reviewed.

Natural Strongyloides infections in rhesus monkeys were used to assess the antistrongyloides activity of pyrvinium pamoate, while gentian violet, dithiazanine iodide, and pyrvinium chloride were tested as reference drugs. All substances were given orally as aqueous suspensions. Pyrvinium pamoate lacked significant effect under test conditions that permitted varying degrees of effect by the reference drugs. These limited comparisons suggested gentian violet to be the most potent of the drugs tested against simian strongyloidiasis.

Author Notes

Save